MARY EVERSOLE: Open Payments
NPI 1669805578 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 40 payments from 18 companies in 2025. Trend: 2023 $10 · 2024 $527 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 4 | $97 |
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Novo Nordisk Inc | 3 | $66 |
| PFIZER INC. | 4 | $64 |
| SCPHARMACEUTICALS INC. | 3 | $63 |
| Kestra Medical Technology Services, Inc. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $49 |
| ABBVIE INC. | 1 | $30 |
Products named: FARXIGA, Kerendia, Ozempic, FUROSCIX, Assure WCD, LEQVIO, ELIQUIS, LifeVest.
Industry payments across IN — which companies pay providers there.
